Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-12

Clinical Trial Update: An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus [Phase 2]

View source ↗

Summary

An open-label Phase 2 study evaluating brexanolone for tinnitus has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brexanolone (allopregnanolone)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Tinnitus | Phase 2 | Status: COMPLETED | Results posted: 2024-12-12